Chloe Botaine

Chloe Botaine

Biopharmaceutical Research Specialist
Chloe Botaine specializes in biopharmaceutical research and development, offering insights into the latest trends, challenges, and breakthroughs in biopharma. Her content covers topics such as drug discovery, clinical trials, and regulatory affairs. With a focus on advancing science and improving patient care, Chloe’s content contributes to the development of innovative therapies and medicines that address unmet medical needs and improve public health outcomes.
NICE Recommends AstraZeneca's Imfinzi with Chemo for Resectable NSCLC
Research & Development NICE Recommends AstraZeneca's Imfinzi with Chemo for Resectable NSCLC

The recent endorsement by the National Institute for Health and Care Excellence (NICE) to utilize AstraZeneca's Imfinzi (durvalumab) in combination with chemotherapy as a treatment for adults with resectable non-small cell lung cancer (NSCLC) marks a significant milestone in cancer care. This

Can AI Technology Revolutionize Neonatal and Maternal Healthcare?
Tech & Innovation Can AI Technology Revolutionize Neonatal and Maternal Healthcare?

The advent of artificial intelligence (AI) in the medical field has long promised revolutionary changes, but one of its latest applications, known as PlacentaVision, may truly transform neonatal and maternal healthcare. Developed by researchers from Northwestern Medicine and Penn State, this

Are Metastatic Breast Cancer Rates Increasing Among U.S. Women?
Research & Development Are Metastatic Breast Cancer Rates Increasing Among U.S. Women?

Breast cancer remains a leading cause of cancer-related deaths among women in the United States. The prognosis of breast cancer is heavily dependent on the stage at which it is diagnosed, with early detection playing a crucial role in improving survival rates. However, recent research indicates a

How is AI Transforming Breast Cancer Screening and Risk Reduction?
Tech & Innovation How is AI Transforming Breast Cancer Screening and Risk Reduction?

Artificial intelligence (AI) is dramatically revolutionizing the field of breast cancer screening and risk reduction by introducing advanced methods for analyzing mammographic images and identifying new risk predictors. With these innovations, the medical community is moving towards more

Can Real-Time Sensors Revolutionize Bone Injury Recovery?
Tech & Innovation Can Real-Time Sensors Revolutionize Bone Injury Recovery?

The use of miniature implantable sensors in the field of bone injury recovery could mark a groundbreaking turn in medical advancements, as demonstrated by researchers at the University of Oregon's Phil and Penny Knight Campus for Accelerating Scientific Impact. Developed through the collaborative

Is HepB-CpG the New Hope for HIV Patients Against Hepatitis B?
Research & Development Is HepB-CpG the New Hope for HIV Patients Against Hepatitis B?

A significant advancement in hepatitis B vaccination has emerged, especially beneficial for individuals living with HIV. According to research led by a Weill Cornell Medicine investigator, a newer hepatitis B vaccine known as HepB-CpG (trade name Heplisav-B) demonstrates substantially superior

Are Hidden Health Risks Lurking in Those with Hereditary Hemochromatosis?
Research & Development Are Hidden Health Risks Lurking in Those with Hereditary Hemochromatosis?

Hereditary hemochromatosis is a genetic condition characterized by excessive iron absorption and storage due to mutations in the HFE gene, particularly the C282Y variant. This condition is especially prevalent in Europe, where many individuals are homozygous for the C282Y mutation. Despite the

Are Montana's New Rules Truly Closing Gaps in Hospital Oversight?
Management & Regulatory Are Montana's New Rules Truly Closing Gaps in Hospital Oversight?

In an effort to crack down on perceived inadequacies in the oversight of nonprofit hospitals’ charitable activities, the state of Montana has rolled out new rules aimed at closing long-standing gaps. This move stems from a legislative audit conducted more than four years ago, which critiqued the

Can High-Fructose Corn Syrup Fuel Cancer Growth and Spread?
Research & Development Can High-Fructose Corn Syrup Fuel Cancer Growth and Spread?

The relationship between dietary fructose, particularly from high-fructose corn syrup, and cancer growth is a topic of growing concern. Over the past few decades, the consumption of high-fructose corn syrup has skyrocketed. While naturally occurring fructose in fruits, vegetables, and honey is

Repurposed Drug Selinexor Shows Promise for Treating KRAS Mutant NSCLC
Research & Development Repurposed Drug Selinexor Shows Promise for Treating KRAS Mutant NSCLC

Recent advances in the fight against non-small cell lung cancer (NSCLC) have brought new hope for patients carrying KRAS mutations, thanks to a breakthrough discovery by researchers at UT Southwestern Harold C. Simmons Comprehensive Cancer Center. This advancement revolves around the repurposing of

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later